Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus (PULSE-OPT)
Primary Purpose
Hydrocephalus, Normal Pressure
Status
Terminated
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Change in shunt opening pressure
Simulated change in shunt opening pressure
Sponsored by
About this trial
This is an interventional treatment trial for Hydrocephalus, Normal Pressure
Eligibility Criteria
Inclusion Criteria:
- Possible or probable INPH according to the INPH guidelines.
- Symptom duration ≥ 3 months
- Age ≥50 years
- Able to walk 10 meters with or without an assistant device.
Decision to recommend shunt surgery based either on:
- Improvement after cerebrospinal fluid (CSF) tap (i.e. positive tap test), or;
- Increased CSF outflow resistance, or;
- A combination of "typical" signs/symptoms + "typical" MRI findings;
- A combination of a-c.
Exclusion Criteria:
- NPH due to hemorrhage, meningitis or stroke (secondary NPH).
- Symptom duration ≥ 5 years.
- Patients considered surgical risk.
- Baseline gait velocity >1.1 m/sec (60 m/min) without assistant device
- Mini Mental State Exam score ≤ 20 points.
- Musculoskeletal condition precluding gait assessment.
- Severe hearing or visual impairment
- Medication in the form of warfarin or novel oral anticoagulant (NOAC)
- Insufficient pressure data below resting pressure during the CSF infusion investigation, i.e. no complete assessment of the pulsatility curve
Sites / Locations
- Kuopio university hospital
- Turku university hospital
- Sahlgrenska university hospital
- Umeå university hospital
- The Uppsala university hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Sham Comparator
Experimental
Arm Label
Fixed opening pressure
Individual shunt opening pressure
Arm Description
The shunt opening pressure is changed to the same setting as at surgery.
The shunt opening pressure is adjusted (up one step, down one step or unchanged) according to an individual analysis of the pulsatility curve (as assessed after shunt surgery).
Outcomes
Primary Outcome Measures
Change in total score on European INPH scale
scale describing the cardinal symptoms of INPH
Gait velocity
Maximal gait velocity (3 x 10 m)
European INPH scale
Change in total score on scale describing the cardinal symptoms of INPH
Gait velocity
Maximal gait velocity (3 x 10 m)
Secondary Outcome Measures
Computerized General Neuropsychological INPH Test (CoGNIT)
A computerized neuropsychological test battery for use in INPH, which produces a total "neuropsychological" score
Timed up and go test
Mobility test: rise from chair, walk 3 m, turn around, walk back and sit down again
EuroQoL's (EQ) standardized 5 dimensions (5D) 5 levels (5L) instrument (EQ-5D-5L™)
EuroQoL's standardized instrument for health outcome, which assesses health in 5 dimensions, on 5 levels
Urogenital Distress Inventory (UDI-6)
Continence assessment scale
Incontinence Impact Questionnaire, Short Form (IIQ-7)
Continence assessment scale
Barthel Index
Activities of daily living assessment scale
Modified Rankin scale
Disability assessment scale
Geriatric depression scale (GDS-15)
Score on a geriatric depression scale consisting of 15 yes/no questions
Mini-mental state examination (MMSE) score
Score on the MMSE scale (general mental status)
Full Information
NCT ID
NCT03076723
First Posted
December 13, 2016
Last Updated
May 16, 2022
Sponsor
Umeå University
Collaborators
Sahlgrenska University Hospital, Sweden, Uppsala University Hospital, Kuopio University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03076723
Brief Title
Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus
Acronym
PULSE-OPT
Official Title
Using Cerebrospinal Fluid Dynamics to Identify Shunt Responders in Idiopathic Normal Pressure Hydrocephalus and to Optimize Postoperative Clinical Improvement While Minimizing Overdrainage Related Complications - A Double Blind Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Terminated
Why Stopped
Acceptable duration exceeded. Enrolment too slow due to covid pandemic and extensive protocol.
Study Start Date
June 13, 2017 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Umeå University
Collaborators
Sahlgrenska University Hospital, Sweden, Uppsala University Hospital, Kuopio University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of the study is to determine if the so called pulsatility curve, which describes the relationship between intracranial pressure (ICP) and ICP pulsatility, can be used to predict outcome of treatment, in the form of shunt surgery, in idiopathic normal pressure hydrocephalus (INPH) and to guide the adjustment of shunt opening pressure after the surgery. The main hypotheses of the study are:
The pulsatility curve may be the best auxiliary test to predict shunt surgery outcome in INPH patients. With a "fixed" shunt opening pressure, the preoperatively assessed potential pulse amplitude reduction (determined by analysis of the pulsatility curve) predicts postoperative improvement in gait velocity and cognitive functions.
A postoperative pulsatility curve can be used to further optimize ICP pulsatility by guiding opening pressure adjustment. Shunt adjustment based on the pulsatility curve three months postoperatively will increase improvement, but not complications, compared to a shunt with "fixed" opening pressure.
Based on these hypotheses, three specific aims for the study have been defined:
To determine if improvement three month after surgery is associated with postoperative reduction in pulse amplitude.
To determine if a pulsatility curve obtained preoperatively can predict improvement in gait velocity and cognitive functions in INPH patients three months after surgery.
To compare outcome six months after surgery and complications rates between INPH patients with a "fixed" opening pressure versus those where the shunt has been adjusted based on the pulsatility curve, three months after the shunt insertion.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hydrocephalus, Normal Pressure
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fixed opening pressure
Arm Type
Sham Comparator
Arm Description
The shunt opening pressure is changed to the same setting as at surgery.
Arm Title
Individual shunt opening pressure
Arm Type
Experimental
Arm Description
The shunt opening pressure is adjusted (up one step, down one step or unchanged) according to an individual analysis of the pulsatility curve (as assessed after shunt surgery).
Intervention Type
Other
Intervention Name(s)
Change in shunt opening pressure
Intervention Description
An individually determined change in shunt opening pressure is compared to no change in opening pressure.
Intervention Type
Other
Intervention Name(s)
Simulated change in shunt opening pressure
Intervention Description
The shunt opening pressure is reset to the same setting.
Primary Outcome Measure Information:
Title
Change in total score on European INPH scale
Description
scale describing the cardinal symptoms of INPH
Time Frame
3 and 6 months after surgery
Title
Gait velocity
Description
Maximal gait velocity (3 x 10 m)
Time Frame
3 and 6 months after surgery
Title
European INPH scale
Description
Change in total score on scale describing the cardinal symptoms of INPH
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Gait velocity
Description
Maximal gait velocity (3 x 10 m)
Time Frame
baseline (before surgery) and 3 months after surgery
Secondary Outcome Measure Information:
Title
Computerized General Neuropsychological INPH Test (CoGNIT)
Description
A computerized neuropsychological test battery for use in INPH, which produces a total "neuropsychological" score
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Timed up and go test
Description
Mobility test: rise from chair, walk 3 m, turn around, walk back and sit down again
Time Frame
baseline (before surgery) and 3 months after surgery
Title
EuroQoL's (EQ) standardized 5 dimensions (5D) 5 levels (5L) instrument (EQ-5D-5L™)
Description
EuroQoL's standardized instrument for health outcome, which assesses health in 5 dimensions, on 5 levels
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Urogenital Distress Inventory (UDI-6)
Description
Continence assessment scale
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Incontinence Impact Questionnaire, Short Form (IIQ-7)
Description
Continence assessment scale
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Barthel Index
Description
Activities of daily living assessment scale
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Modified Rankin scale
Description
Disability assessment scale
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Geriatric depression scale (GDS-15)
Description
Score on a geriatric depression scale consisting of 15 yes/no questions
Time Frame
baseline (before surgery) and 3 months after surgery
Title
Mini-mental state examination (MMSE) score
Description
Score on the MMSE scale (general mental status)
Time Frame
baseline (before surgery) and 3 months after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Possible or probable INPH according to the INPH guidelines.
Symptom duration ≥ 3 months
Age ≥50 years
Able to walk 10 meters with or without an assistant device.
Decision to recommend shunt surgery based either on:
Improvement after cerebrospinal fluid (CSF) tap (i.e. positive tap test), or;
Increased CSF outflow resistance, or;
A combination of "typical" signs/symptoms + "typical" MRI findings;
A combination of a-c.
Exclusion Criteria:
NPH due to hemorrhage, meningitis or stroke (secondary NPH).
Symptom duration ≥ 5 years.
Patients considered surgical risk.
Baseline gait velocity >1.1 m/sec (60 m/min) without assistant device
Mini Mental State Exam score ≤ 20 points.
Musculoskeletal condition precluding gait assessment.
Severe hearing or visual impairment
Medication in the form of warfarin or novel oral anticoagulant (NOAC)
Insufficient pressure data below resting pressure during the CSF infusion investigation, i.e. no complete assessment of the pulsatility curve
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan Malm, MD, PhD
Organizational Affiliation
Umeå University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sara Qvarlander, PhD
Organizational Affiliation
Umeå University
Official's Role
Study Director
Facility Information:
Facility Name
Kuopio university hospital
City
Kuopio
ZIP/Postal Code
70210
Country
Finland
Facility Name
Turku university hospital
City
Turku
ZIP/Postal Code
20521
Country
Finland
Facility Name
Sahlgrenska university hospital
City
Gothenburg
ZIP/Postal Code
41345
Country
Sweden
Facility Name
Umeå university hospital
City
Umeå
ZIP/Postal Code
90185
Country
Sweden
Facility Name
The Uppsala university hospital
City
Uppsala
ZIP/Postal Code
75185
Country
Sweden
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus
We'll reach out to this number within 24 hrs